Clinical Trial

/Tag: Clinical Trial

It’s a Journey: Our Experience on Clinical Trials

By Jennifer Moore, LRG Member I was waiting in line to pick up a new prescription for Gleevec when my husband ran in and told me to forget it. After two surgeries, a year [...]

By |2018-10-29T13:46:42+00:00December 28th, 2017|Clinical Trials, Member Stories, News, Newsletter|

New Data Indicates Imatinib Boosts Long-Term Survival for Some GIST Patients

A significant finding from a newly published study in JAMA Oncology, indicates that nearly one-fourth of GIST patients with advanced disease initially treated with imatinib will survive for ten years or more. The study, [...]

By |2018-10-30T09:19:32+00:00February 27th, 2017|News, Research|

Study Indicates Use Of Adjuvant Imatinib Therapy For GIST Increasing

A recent study published in the American Journal of Clinical Oncology found that the use of adjuvant systemic therapy with imatinib for GIST has increased significantly over time, and that patients treated with the therapy [...]

By |2018-09-11T09:21:47+00:00April 7th, 2015|Drug Treatment, Gleevec, News, Survival Strategies|

Phase II Clinical Trial in Australia

A Phase II clinical trial comparing Imatinib alternated with Regorafenib to Imatinib alone is currently underway and recruiting in Australia. The trial, sponsored by the Australasian Gastro-Intestinal Trials Group (http://agitg.org.au), looks to examine the feasibility [...]

By |2015-03-11T15:50:52+00:00March 12th, 2015|Clinical Trials, Global, News|

Novartis gains approval for panobinostat

Novartis Pharmaceuticals recently received FDA approval for panobinostat, a blood cancer drug that targets multiple myeloma. This was a surprising ruling, as it was a turnaround from last year’s Oncologic Drugs Advisory Committee’s 5-2 vote [...]

By |2015-03-09T11:53:15+00:00March 9th, 2015|Clinical Trials, Drug Treatment, News|

Recent Posts

Upcoming Events

  1. GIST Laugh

    March 8 @ 7:00 PM - 10:00 PM
  2. GIST DO IT NJ

    May 4 @ 8:00 AM - 11:00 AM